DOI: 10.1055/s-00023610

Drug Research

Issue 07 · Volume 72 · September 2022 DOI: 10.1055/s-012-55041

Review

355
Pandey, Jaya; Dubey, Ragini; Kate, Aditya; Prasad, Bhairav; Sinha, Arzoo; Mishra, Mohit S: Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement
367
Rajesh, Kumar; Khan, M I; Mahesh, Prasad; Kumar, Srivastav Ritesh; Kumar, Srivastav Shiv: Preclinical and Clinical Role of Coenzyme Q10 Supplementation in Various Pathological States

Original Article

372
Tanaka, Motoharu; Abe, Shigeru: Effects of Liposome-Entrapped Muramyl Tripeptide Phosphatidylethanolamine (L-MTP-PE) on the Tumor Growth and Survival of Mice Bearing Syngeneic Tumor in Combination with a Chemotherapeutic or Immunomodulatory Agent
378
Malakoti, Faezeh; Majidinia, Maryam; Ahmadi, Yasin; Yousefi, Bahman; Shanebandi, Darioush: Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells
385
Ahmadi, Mehran; Valizadeh, Amir; Bazavar, Mohammadreza; Yousefi, Bahman: Investigating the Role of Quercetin in Increasing the Rate of Cisplatin-Induced Apoptosis Via the NF-κB Pathway in MG-63 Cancer Cells
390
khyavi, Payam Ali; Valizadeh, Amir; Shanehbandi, Dariush; Yousefi, Bahman; Soleimanpour, Jafar: Thymoquinone Potentiates Methotrexate Mediated-Apoptosis in Saos-2 Osteosarcoma Cell Line
396
Famurewa, Ademola C.; Aja, Patrick M.; Medewase, John O.; Abi, Innocent; Ogbonna, Okoro C.; Ofor, Casimir C.; Nwonuma, Charles O.; Asogwa, Nnaemeka T; Erejuwa, Omotayo O.: Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Exhibits Antioxidant Mechanism for Abrogation of Cyclophosphamide-Induced Cardiac Damage and Oxidative Hepatorenal Toxicity in Rats
404
Lauro, Figueroa-Valverde; Marcela, Rosas-Nexticapa; Maria, López-Ramos; Magdalena, Alvarez-Ramirez; Virginia, Mateu-Armad Maria; Francisco, Díaz-Cedillo; Alejandra, Garcimarrero-Espino; Tomas, Lopez Gutierrez; Montserrat, Melgarejo-Gutierrez: Evaluation of Biological Activity of a Diazocine Derivative against Heart Failure Using an Ischemia-Reperfusion Injury Model